Detalles de la búsqueda
1.
Novel susceptibility loci for steroid-associated osteonecrosis of the femoral head in systemic lupus erythematosus.
Hum Mol Genet
; 31(7): 1082-1095, 2022 03 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-34850884
2.
Reduced-dose versus high-dose glucocorticoids added to rituximab on remission induction in ANCA-associated vasculitis: predefined 2-year follow-up study.
Ann Rheum Dis
; 83(1): 96-102, 2024 Jan 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37734880
3.
Clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of microscopic polyangiitis and granulomatosis with polyangiitis: The 2023 update - secondary publication.
Mod Rheumatol
; 34(3): 559-567, 2024 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37599461
4.
Predictors of damage accrual in patients with antineutrophil cytoplasmic antibody-associated vasculitis: A nationwide prospective study.
Mod Rheumatol
; 34(2): 382-390, 2024 Feb 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-36988333
5.
Evaluation of Ministry of Health, Labour and Welfare diagnostic criteria for antineutrophil cytoplasmic antibody-associated vasculitis compared to ACR/EULAR 2022 classification criteria.
Mod Rheumatol
; 34(3): 551-558, 2024 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37279574
6.
Validation of new ACR/EULAR 2022 classification criteria for anti-neutrophil cytoplasmic antibody-associated vasculitis.
Mod Rheumatol
; 34(1): 144-150, 2023 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36715080
7.
Chemoprophylaxis against Pneumocystis jirovecii pneumonia in Japanese patients with ANCA-associated vasculitis: An observational study.
Mod Rheumatol
; 33(6): 1137-1144, 2023 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36197746
8.
Integrated safety analysis of filgotinib treatment for rheumatoid arthritis in patients from Japan over a median of 1.5 years.
Mod Rheumatol
; 33(1): 64-72, 2023 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35365828
9.
Nation-wide cohort study of remission induction therapy using rituximab in Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis: Effectiveness and safety in the first 6 months.
Mod Rheumatol
; 33(6): 1117-1124, 2023 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36478050
10.
Safety and efficacy of filgotinib for Japanese patients with RA and inadequate response to MTX: FINCH 1 52-week results and FINCH 4 48-week results.
Mod Rheumatol
; 33(4): 668-679, 2023 Jul 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35920102
11.
Long-term safety and efficacy of filgotinib treatment for rheumatoid arthritis in Japanese patients naïve to MTX treatment (FINCH 3).
Mod Rheumatol
; 33(4): 657-667, 2023 Jul 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35921235
12.
Selection of treatment regimens based on shared decision-making in patients with rheumatoid arthritis on remission in the FREE-J study.
Rheumatology (Oxford)
; 61(11): 4273-4285, 2022 11 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35136990
13.
Nation-wide survey of the treatment trend of microscopic polyangiitis and granulomatosis with polyangiitis in Japan using the Japanese Ministry of Health, Labour and Welfare Database.
Mod Rheumatol
; 32(5): 915-922, 2022 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-34918136
14.
Efficacy and safety of filgotinib in Japanese patients with refractory rheumatoid arthritis: Subgroup analyses of a global phase 3 study (FINCH 2).
Mod Rheumatol
; 32(1): 59-67, 2022 01 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33274687
15.
Efficacy and safety of filgotinib in combination with methotrexate in Japanese patients with active rheumatoid arthritis who have an inadequate response to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 1).
Mod Rheumatol
; 32(2): 263-272, 2022 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-34910188
16.
Efficacy and safety of filgotinib alone and in combination with methotrexate in Japanese patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 3).
Mod Rheumatol
; 32(2): 273-283, 2022 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-34910203
17.
Clinical impact of urinary CD11b and CD163 on the renal outcomes of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
Nephrol Dial Transplant
; 36(8): 1452-1463, 2021 07 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-32639002
18.
Effect of Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab on Remission Induction in ANCA-Associated Vasculitis: A Randomized Clinical Trial.
JAMA
; 325(21): 2178-2187, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34061144
19.
Rationale of concomitant cyclophosphamide for remission-induction in patients with antineutrophil cytoplasmic antibody-associated vasculitis: A propensity score-matched analysis of two nationwide prospective cohort studies.
Mod Rheumatol
; 31(1): 205-213, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31859544
20.
Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial.
Ann Rheum Dis
; 79(1): 94-102, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31630117